8.92% volatility in Mereo Biopharma Group Plc ADR (MREO) last month: This is a red flag warning

On November 20, 2023, Mereo Biopharma Group Plc ADR (NASDAQ: MREO) opened at $2.10, higher 5.29% from the last session. During the day, the shares moved up to $2.23 and dropped to $2.03 before settling in for the closing price of $2.08. Price fluctuations for MREO have ranged from $0.49 to $2.39 over the past 52 weeks.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -20.00%. Company’s average yearly earnings per share was noted 28.34% at the time writing. With a float of $128.36 million, this company’s outstanding shares have now reached $128.39 million.

The extent of productivity of a business whose workforce counts for 36 workers is very important to gauge.

Mereo Biopharma Group Plc ADR (MREO) Insider Updates

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Mereo Biopharma Group Plc ADR is 0.02%, while institutional ownership is 57.25%.

Mereo Biopharma Group Plc ADR (MREO) Performance Highlights and Predictions

This company achieved a return on equity of -43.51. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 28.34% per share during the next fiscal year.

Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Trading Performance Indicators

Check out the current performance indicators for Mereo Biopharma Group Plc ADR (MREO). In the past quarter, the stock posted a quick ratio of 3.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 31.99.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.25 and is forecasted to reach -0.03 in one year’s time.

Technical Analysis of Mereo Biopharma Group Plc ADR (MREO)

The latest stats from [Mereo Biopharma Group Plc ADR, MREO] show that its last 5-days average volume of 0.99 million was inferior to 1.33 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 50.67%. Additionally, its Average True Range was 0.17.

During the past 100 days, Mereo Biopharma Group Plc ADR’s (MREO) raw stochastic average was set at 84.85%, which indicates a significant increase from 60.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.26% in the past 14 days, which was lower than the 77.92% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.67, while its 200-day Moving Average is $1.27. Now, the first resistance to watch is $2.27. This is followed by the second major resistance level at $2.35. The third major resistance level sits at $2.47. If the price goes on to break the first support level at $2.07, it is likely to go to the next support level at $1.95. Assuming the price breaks the second support level, the third support level stands at $1.87.

Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Key Stats

There are currently 124,986K shares outstanding in the company with a market cap of 281.17 million. Presently, the company’s annual sales total 0 K according to its annual income of -42,300 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Lumen Technologies Inc (LUMN) 20 Days SMA touches -3.68%: The odds favor the bear

Lumen Technologies Inc (NYSE: LUMN) on November 27, 2023, started off the session at the price of $1.26, plunging -2.38% from the previous trading...

Can Transocean Ltd’s (RIG) drop of -2.31% in a week be considered a lucky break?

November 27, 2023, Transocean Ltd (NYSE: RIG) trading session started at the price of $6.46, that was -3.20% drop from the session before. During...

Ginkgo Bioworks Holdings Inc (DNA) kicked off at the price of $1.39: Venture capitalists have an exciting new opportunity

On November 27, 2023, Ginkgo Bioworks Holdings Inc (NYSE: DNA) opened at $1.44, lower -4.79% from the last session. During the day, the shares...


Please enter your comment!
Please enter your name here